No Picture
News

OnQuality Announces FDA Clearance of IND Application for OQL036 for the Prophylaxis of Capecitabine-Induced Hand-Foot Syndrome

SEATTLE, April 28, 2023 /PRNewswire/ — OnQuality Pharmaceuticals (“OnQuality”), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in oncodermatology and oncogastroenterology (cancer therapy-induced toxicities occurring in the skin and… Click […]

No Picture
News

Prescryptive Health Previews Point-of-Care Solution for Pharma Manufacturers at Asembia’s AXS23 Summit

New offering will engage, inform, and empower the healthcare consumer to drive product utilization, adherence, and real-time data to help pharma manufacturers meet their goals. REDMOND, Wash. , April 27, 2023 /PRNewswire/ — Prescryptive Health, […]

No Picture
News

A Decade of Progress Treating Panic Disorder and PTSD: Freespira Marks 10 Years of Innovation and Life-Changing Impact on Mental Health

17 million Americans now have access to the pioneering at-home treatment KIRKLAND, Wash., April 26, 2023 /PRNewswire/ — Freespira, developer of the only FDA-cleared at-home treatment for panic disorder, panic attacks and post-traumatic stress disorder […]